Resumen
This study aimed to evaluate the pharmacological trends in patients with COVID-19 from a hospital in Peru during the first wave of the pandemic. Retrospective study conducted between April and September 2020. The medical records of patients hospitalized for COVID-19 pneumonia at the Dos de Mayo National Hospital (Lima, Peru) were reviewed. Of a total of 3103 patients, 381 medical records were included (77.4% male, median age: 44 years). The use of four prehospital drugs increased (azithromycin, ivermectin, corticosteroids, and ceftriaxone), while the in-hospital use of six drugs (ceftriaxone, azithromycin, hydroxychloroquine, ivermectin, corticosteroid pulse, and prophylactic anticoagulation) decreased and in-hospital anticoagulation use decreased. These findings suggest that the management of COVID-19 has varied during the first wave of the pandemic, typically increasing prehospital drug use and decreasing inpatient use.
Título traducido de la contribución | TRENDS IN DRUGS USAGE FOR COVID-19 DURING THE FIRST WAVE OF THE PANDEMIC IN A HOSPITAL IN LIMA, PERU |
---|---|
Idioma original | Español |
Páginas (desde-hasta) | 608-614 |
Número de páginas | 7 |
Publicación | Revista Peruana de Medicina Experimental y Salud Publica |
Volumen | 38 |
N.º | 4 |
DOI | |
Estado | Publicada - 2021 |
Palabras clave
- Anti-bacterial Agents
- COVID-19
- Dexamethasone
- Drugs Utilization
- Epidemiologic Factors
- Hospitalization
- Peru
- Pneumonia
- Therapeutics
- Trends